$1.62 +0.02 (1.25%) Cormedix Inc - NYSE Amex Equities

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 1.62
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: +0.02 (1.25%)
Prev Close: 1.60
Open: 1.64
Bid: 1.50
Ask: 1.74
  1. No results found.
  1. Benzinga's Top Initiations

    Benzinga | Nov. 12, 2015 | 10:08AM EST
  2. Pacific Premier Bancorp, Inc. Announces the Appointment of New Director

    Benzinga | Oct. 7, 2015 | 05:00AM EST
  3. Exclusive: Elliott's Paul Singer Says Rumors Of Yahoo Position Are Not True

    Benzinga | Aug. 13, 2015 | 15:16PM EST
  4. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ...

    GuruFocus | Aug. 7, 2015 | 23:03PM EST
  5. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold Dwindles

    Benzinga | Jul. 20, 2015 | 11:03AM EST
  6. Morning Market Losers

    Benzinga | Jul. 20, 2015 | 08:53AM EST
  7. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. ...

    GuruFocus | Jul. 16, 2015 | 23:03PM EST
  8. Morning Market Gainers

    Benzinga | Jun. 17, 2015 | 08:42AM EST
  9. Paul Singer Adds to Six Stakes in First Quarter

    GuruFocus | May. 21, 2015 | 18:02PM EST
  10. CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the US

    GuruFocus | Oct. 27, 2014 | 11:05AM EST
  11. Morning Market Movers

    Benzinga | Oct. 27, 2014 | 08:55AM EST
  12. Morning Market Movers

    Benzinga | Jun. 24, 2014 | 08:40AM EST
  13. CorMedix Welcomes Additional Board Members

    Benzinga | Apr. 7, 2014 | 07:33AM EST
  14. CorMedix to Raise $2,M in Offering

    Benzinga | Jan. 8, 2014 | 09:23AM EST
  15. CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA

    Benzinga | Dec. 23, 2013 | 09:53AM EST
Trading Center